NAZANIN FIROOZ M.D. NPI 1447437967

NPI Information

  • NPI: 1447437967
  • Provider Name: NAZANIN FIROOZ, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 23067 VENTURA BLVD STE 200
    WOODLAND HILLS, CA
    ZIP 91364
  • Phone: (818) 598-0000

Map and Directions

Get Directions

NPI Details

Nazanin Firooz, M.D. is a rheumatology internal medicine in Woodland Hills, CA with 21 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Nazanin Firooz, M.D. NPI is 1447437967. The provider is registered as an individual entity type and is a single specialty group.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Graduation Year:2004

The provider's business location address is:

23067 VENTURA BLVD STE 200
WOODLAND HILLS, CA
ZIP 91364-113
Phone: (818) 598-0000
Fax: (818) 598-0500

The NPI 1447437967 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • X-ray of wrist, 2 views (HCPCS:73100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • X-ray of foot, 2 views (HCPCS:73620)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, adrenalin, epinephrine, 0.1 mg (HCPCS:J0171)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 1/28/2008 and was last updated on 5/22/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyA96204CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11215358320MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.